Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Merck KGaA (OTC:MKGAF) is seeking worldwide regulatory approval for its CSF-1R inhibitor pimicotinib following robust Phase ...

After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target of $100.00. The companys ...

Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...

Alzheimer’s disease is currently diagnosed with expensive medical imaging or invasive methods that require a spinal tap. Patients now have an alternative. The FDA has cleared a new Fujirebio ...

Leerink Partnrs also issued estimates for Arcturus Therapeutics’ Q3 2025 earnings at ($0.88) EPS, Q4 2025 earnings at ($1.04) EPS, FY2025 earnings at ($3.32) EPS and FY2026 earnings at ($4.11 ...

Now in its landmark 75 th year, Regeneron ISEF remains the premier global stage for the next generation of scientists and engineers. This milestone year celebrates decades of scientific discovery ...

A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and the FDA scheduled an advisory meeting.

POLK COUNTY, Fla. (WFLA) — The Polk County Sheriff’s Office announced Thursday that 255 were arrested in a nine-day, multi-agency undercover investigation called “Fool Around and Find Out ...